Sign In
Buy ALC
$64.22
-0.0600 (-0.0933%)
At Close: Jun 03, 2026
ALC or EW: Which Is the Better Value Stock Right Now?
12:56pm, Friday, 28'th Apr 2023
Investors interested in Medical - Instruments stocks are likely familiar with Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
ALC vs. IDXX: Which Stock Is the Better Value Option?
12:55pm, Wednesday, 12'th Apr 2023
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a be
What Makes Alcon (ALC) a New Buy Stock
01:41pm, Monday, 10'th Apr 2023
Alcon (ALC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ALC vs. ISRG: Which Stock Is the Better Value Option?
12:59pm, Monday, 20'th Mar 2023
ALC vs. ISRG: Which Stock Is the Better Value Option?
Alcon (ALC) Unveils Expansive Vision Care Products at SECO 2023
10:32am, Monday, 06'th Mar 2023
Alcon (ALC) showcases its reusable toric lens and dry eye/ocular health offerings at the SECO International Meeting 2023 in Atlanta.
ALC vs. ISRG: Which Stock Should Value Investors Buy Now?
12:47pm, Thursday, 02'nd Mar 2023
ALC vs. ISRG: Which Stock Is the Better Value Option?
Alcon Inc. (ALC) Q4 2022 Earnings Call Transcript
12:54pm, Tuesday, 28'th Feb 2023
Alcon Inc. (NYSE:ALC ) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Dan Cravens - Vice President & Global Head of Investor Relations David Endicott - Chief Execut
Alcon: Case Of Growth Destructive To Value, Reiterate Hold At 24x Earnings
12:32pm, Wednesday, 01'st Feb 2023
A firm creates value when its return on invested capital exceeds its cost of capital. If it doesn't, regardless of its expansion, growth will become destructive to shareholder value.
Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio
03:48pm, Thursday, 24'th Nov 2022
Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.
Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut
12:03pm, Wednesday, 23'rd Nov 2022
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the strength in its comprehensive portfolio of PCIOLs, including PanOptix and Vivity.
Alcon: Eyeing A Growth Story That Could Benefit From A Weaker Dollar
02:31am, Friday, 18'th Nov 2022
It's rare to find a high-growth foreign company that isn't stuck in a big downtrend. While ALC shares are down sharply year-on-year, its valuation is not so bad considering impressive EPS growth.
Alcon Inc. (ALC) Q3 2022 Earnings Call Transcript
12:30pm, Wednesday, 16'th Nov 2022
Alcon Inc. (NYSE:ALC ) Q3 2022 Earnings Conference Call November 16, 2022 8:00 AM ET Company Participants Dan Cravens - Vice President and Global Head, Investor Relations David Endicott - Chief Execut
Alcon (ALC) Faces Cost Pressure, Supply Chain Disruption
01:32pm, Tuesday, 13'th Sep 2022
Given the supply chain challenges, unfavorable foreign exchange impact and inflationary pressure, Alcon (ALC) reduces its core EPS and net sales expectations for 2022.
Alcon: Looking To Break Downtrend Before Entry
04:04am, Sunday, 04'th Sep 2022
Alcon has continued in a downtrend since September 2021 with persistent mean reversion activity across this time. With FY22 guidance narrowed and macro-headwinds prevailing, forward-looking multiples
Don't Look for Alcon's Acquisition to Boost Share Price in Short Term
04:02pm, Wednesday, 24'th Aug 2022
Most investors would probably be pleased with a share price gain of 33% in just over three years, but more than 50% sounds a lot better.
